home / stock / bwv / bwv news


BWV News and Press, Blue Water Vaccines Inc. From 08/15/23

Stock Information

Company Name: Blue Water Vaccines Inc.
Stock Symbol: BWV
Market: NASDAQ

Menu

BWV BWV Quote BWV Short BWV News BWV Articles BWV Message Board
Get BWV Alerts

News, Short Squeeze, Breakout and More Instantly...

BWV - Flexibility Matters

2023-08-15 21:41:00 ET Summary The U.S. equity market in 2023 has been driven by the disproportionate outperformance of large cap, growth, and technology-oriented stocks, leading to a significant concentration of market returns. The Large-Cap Growth and technology-oriented segment...

BWV - Blue Water Biotech to build copay assistance programs for its products

2023-08-10 13:08:53 ET Biotechnology company Blue Water Biotech ( NASDAQ: BWV ) Thursday announced signing of an agreement with Copay Consultants. Agreement to build copay assistance programs for Blue Water’s commercial products. This new agreement is expected to he...

BWV - Matrix Asset Advisors Q2 2023 Capital Markets Commentary And Quarterly Report

2023-08-10 09:15:00 ET Summary Matrix Asset Advisors is a Value-Driven asset management company. Our investment philosophy and process has allowed us to build a cohesive team of key investment professionals, enabling us to be both opportunistic and responsive. The S&P 500 cont...

BWV - Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water's Commercial Products

CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology and pharmaceutical company spanning multiple sectors, today announced the signing of an agreement with Copay Consultants, LLC (“Copay Consulta...

BWV - Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

CINCINNATI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), today announced the closing of its previously announced exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a red...

BWV - Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

CINCINNATI, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the “Company”) (Nasdaq: BWV), today announced it has entered into a definitive agreement for the exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a reduce...

BWV - Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenge...

BWV - July 2023 Equity Market Outlook: Positive Sentiment Emerges As Inflation Slows

2023-07-26 22:39:00 ET Summary Q2 2023 was a more favorable environment for Emerging Markets, Europe, Australia and Real Assets managers. There was no single style factor that dominated returns across markets, with country and sector positioning being more relevant. Managers a...

BWV - Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenge...

BWV - Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenge...

Previous 10 Next 10